Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRO
CRO
Charles River to cuts costs, shift direction as revenue slides
The CRO giant plans to shed “underperforming or non-core” parts of its business while investing in animal testing alternatives.
Darren Incorvaia
Nov 5, 2025 12:54pm
Thermo Fisher to buy Clario in $9B deal
Oct 31, 2025 12:41pm
Roche's Flatiron Health debuts 6 new blood cancer data sets
Oct 29, 2025 9:00am
Lilly, Nvidia team up to build industry-leading supercomputer
Oct 28, 2025 3:26pm
WuXi sharpens focus by selling off clinical research units
Oct 28, 2025 12:27pm
Psychiatrist launches new CRO with patient-centered focus
Oct 22, 2025 2:22pm
